enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Donanemab - Wikipedia

    en.wikipedia.org/wiki/Donanemab

    Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. [1] [2] Donanemab was developed by Eli Lilly and Company. [3] [4] The most common side effects include amyloid-related imaging abnormalities and headache. [2] Donanemab was approved for medical use in the United States in July 2024.

  3. US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10

    www.aol.com/news/us-fda-panel-discuss-eli...

    Lilly's donanemab was declined accelerated approval by the FDA in January 2023, and on March 8, the agency said it would hold a meeting of its advisers to discuss the drug, further delaying its ...

  4. Anti-amyloid drugs - Wikipedia

    en.wikipedia.org/wiki/Anti-amyloid_drugs

    Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. [31] [32] Donanemab was developed by Eli Lilly and Company. [33] [34] The most common side effects include amyloid-related imaging abnormalities and headache. [32] Donanemab was approved for medical use in the United States in ...

  5. Eli Lilly Alzheimer's drug to be blocked for use by NHS, The ...

    www.aol.com/news/eli-lilly-alzheimers-drug...

    A decision on donanemab has been delayed, with the regulatory agency initially planning to make a call in July, the same time it was approved for use in the U.S., the report said.

  6. Donanemab – what we know about the latest Alzheimer’s drug

    www.aol.com/donanemab-know-latest-alzheimer-drug...

    Donanemab, also known as Kisunla, was found to slow the rate at which memory and thinking get worse by more than 20%. Results also suggest the drug leads to a 40% reduction in the decline of ...

  7. List of fake news websites - Wikipedia

    en.wikipedia.org/wiki/List_of_fake_news_websites

    The Washington Post submitted a complaint against Coler's registration of the site with GoDaddy under the UDRP, and in 2015, an arbitral panel ruled that Coler's registration of the domain name was a form of bad-faith cybersquatting (specifically, typosquatting), "through a website that competes with Complainant through the use of fake news ...

  8. Everything we know about breakthrough Alzheimer’s drug Donanemab

    www.aol.com/everything-know-breakthrough...

    Donanemab is a monoclonal antibody that binds to a protein that builds up in the brain during the early stages of Alzheimer’s. According to Alzheimer’s Society, the drug is a disease-modifying ...

  9. Talk:Donanemab - Wikipedia

    en.wikipedia.org/wiki/Talk:Donanemab

    Here are links to possibly useful sources of information about Donanemab. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC